AllSight
Companies · BDX · Surgical & Medical Instruments & Apparatus

BECTON DICKINSON & CO (BDX)

BECTON DICKINSON & CO (BDX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

BECTON DICKINSON & CO (BDX) stock — financials & valuation

Key numbers for BECTON DICKINSON & CO (BDX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 43/100 — a percentile rank of BECTON DICKINSON & CO’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.

Market cap$48.8B
P / E51.8×
P / S2.3×
EV / EBITDA11.7×
Gross margin46.4%
Operating margin11.2%
Net margin4.5%
Return on equity3.9%
ROIC5.0%
Revenue growth5.2%
Debt / equity0.7×
Dividend yield2.4%

Is BECTON DICKINSON & CO overvalued? P/E looks overvalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from BECTON DICKINSON & CO’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Quarterly beat and guidance floor lifted, but underlying growth remains modest
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact